FEMSelect is a Woman-Led Company
The FEMSelect team brings together decades of experience in developing innovative Medtech solutions designed to improve the quality of life for patients worldwide. We’re driven by a shared passion for advancing care and empowering better outcomes.
Dr. Peter Fitzgerald
Triventures
- ▸ Co-Founder & Managing Partner, Triventures
- ▸ Director, Center for Cardiovascular Technology, Stanford University
Renee Selman
Former Worldwide President, Ethicon Women’s Health And Urology
- ▸ Industry expert and Angel investor, Robin Hood Ventures
- ▸ Former Interim CCO of Agile Therapeutics (women’s health)
- ▸ Former Worldwide President of Ethicon Women’s Health and Urology (division of J&J)
Rakesh Tailor
CEO, Contura International
- ▸ CEO, Contura International
- ▸ Rakesh led Contura’s global success of Bulkamid® for the treatment of stress urinary incontinence (SUI) and its sale to Axonics Modulation Technologies for US$200 million in February 2021.
Jim Martin
CEO, Nordwand Capital
- ▸ 30+ years experience in Wealth Management
- ▸ Former Managing Director at Morgan Stanley
- ▸ Former Director at Credit Suisse Private Banking North America
Carmi Zisapel
Radbiomed (Board Observer)
- ▸ Portfolio Manager, RAD BioMed
- ▸ Managing Director at the RAD Bynet group
Volker Berl
Founder & Managing Partner, New Age Ventures
- ▸ Founder & Managing Partner, New Age Ventures
- ▸ Board Member of Standard Lithium (NYSE:SLI), Gaussin (EPA:ALGAU), FTAC Zeus Acquisition Corp and other private companies.
Debbie Garner
President, Femselect
- ▸ President
- ▸ 20+ years of experience in commercialization roles in pharma and medical device companies including Eli Lilly and Co. and iMDsoft
- ▸ MBA, Wharton School of Business, University of Pennsylvania
- ▸ BA, Harvard College
Sasha Schrode
Chief Executive Officer, Femselect
- ▸ Chief Executive Officer
- ▸ 20 years experience in the life science industry with Schering Plough, CR Bard and Medcomp and then Founder and CEO of Serpex Medical, which was sold to Maverix Medica
- ▸ Partner at Robin Hood Ventures
Dani Goldsher
CFO, Triventures
- ▸ CFO, Triventures
- ▸ Founder and Former CEO, Solidon Ltd.
- ▸ Former CFO, Jets Investment, Former Auditor, Deloitte
Sasha Schrode
CEO
Sasha Schrode is the CEO of FEMSelect and a member of the company’s board of directors. Sasha brings over 20 years of experience in healthcare where she has focused on addressing the needs of the evolving healthcare landscape by driving improvements to patient outcomes and increasing healthcare economic efficiency. Prior to joining FEMSelect, she founded Serpex Medical, a MedTech company that was acquired in 2023. Under her leadership, she has brought transformational MedTech innovations to market while creating value to shareholders.
Sasha is also a Partner at Robin Hood Ventures and serves on the board of FEMSelect, The American Lung Association, Cooler Heads, University of Penn’s Health Technology and is an advisor to FloBio and RTM Vital Signs. She has a B.A in Business Administration and a M.B.A in Finance and Healthcare Administration. Sasha is passionate about advancing women’s health and leveraging her expertise to deliver impactful solutions worldwide.
Debbie Garner
Debbie has 20 years of experience in commercialization leadership roles. She has launched and built the market for innovative women’s health care products with Eli Lilly and Co. and iMDsoft in numerous international markets. Debbie holds an MBA from the Wharton School of Business of the University of Pennsylvania and a BA from Harvard College.
Joel Chechik
Joel brings 20+ years of Sales and Marketing leadership to FEMSelect, having served in sales leadership roles with Coloplast, Medtronic and NeoTract. He has led targeted marketing and sales expansion initiatives driving adoption of minimally invasive, cardiac and urologic implantable technologies. Joel is a hands-on US-based sales leader who can show a sales team how to work with key opinion leader physicians who need to learn and become confident with a new procedure, before recommending that procedure to patients and to colleagues in their practice and medical center.
Karla Loken DO ObGyn FACOOG
Dr Loken brings years of experience in Medical Affairs for several global therapeutics and medical device companies as well as 20+ years of women’s health experience in private practice, medical education and academics – which have prepared her to drive adoption of this innovative new approach to treating Pelvic Organ Prolapse.
Prof. Menahem Neuman
Menahem is currently Head of Urogynecology, Galilee Medical Center and Bar-Ilan University. Prior to this, he was Ethicon Women’s Health & Urology PFR global trainer and Pelvic Floor Innovation Committee Member.
Boaz Harari
Boaz has over 20 years of experience in the medical device field. Former CTO of VibeMedic Ltd. and Niti Surgical Solutions Ltd. He is an experienced engineer who has developed numerous clinical devices from concept to market.
Sherwyn Davidson
Sherwyn is an experienced medical device Quality Management and Regulatory professional. He has over 20 years of experience interacting with regulatory authorities and establishing and maintaining a Quality Management System with more than 10 years as Senior Project Manager at Medicsense Ltd., a leading Israeli consulting firm. Sherwyn holds a B.Sc. in Industrial Engineering from Ben-Gurion University.
